While the technical work is being done to support it, I would like to see some more information around the strategy for NOXcovid and pharmorage. I'd be happier to see this spun off either though licensing to existing co or into a separate vehicle and dilute ownership in return for funding to progress. If neither of these are attractive then got to question why NOX would continue to invest in it.
